A New Type of Evidence by Dawn Lemmane

March 17, 2016

17944439715_8eff7a70af_o

From the Quantified Self Public Health Symposium

“We are turning the evidence pyramid on its head. We think the single subject trial should be at the top of that pyramid.”

Dawn Lemanne, the founder of Oregon Integrative Oncology, is a pioneering clinician who brings powerful tools of patient involvement and self-assessment to evaluating treatment options. A widely respected researcher, she also organizes the Independent Metabolic Research Group (iMeRG) based in Southern Oregon, a group of over 40 licensed healthcare professionals who meet regularly to discuss their individual single-subject research studies. Here, Dawn describes some of the research her group is conducting, reflecting on what our future concepts of evidence may be when single subject research becomes more commonplace.

Watch Dawn’s talk on Medium.

Related Posts

An N-of-1 experiment helps a physician identify the trigger of painful swallowing.

Gary Wolf

March 25, 2019

Dr. Alexander Smith found the trigger of his throat pain by eliminating a likely culprit from his diet: dairy. He noted that the pain disappeared, and then reintroducing the offending food and noticing that the pain came back. This simple protocol substituted for a much more difficult process that is typically recommended, saving him a lot of time, stress, and money.

Quantified Self Guide to Tracking Cholesterol and Triglycerides

Azure Grant

November 8, 2017

From the Quantified Self Public Health Symposium “We are turning the evidence pyramid on its head. We think the single subject trial should be at the top of that pyramid.” Dawn Lemanne, the founder of Oregon Integrative Oncology, is a pioneering clinician who brings powerful tools of patient involvement and self-assessment to evaluating treatment options....